37.5 USD
-0.01 (-0.03%)
37.5 USD
0 (0%)
Overall AZTA gets a fundamental rating of 4 out of 10. We evaluated AZTA against 57 industry peers in the Life Sciences Tools & Services industry. While AZTA has a great health rating, there are worries on its profitability. AZTA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AZTA was profitable.
AZTA had a positive operating cash flow in the past year.
In multiple years AZTA reported negative net income over the last 5 years.
Of the past 5 years AZTA 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -2.71%, AZTA is in line with its industry, outperforming 54.39% of the companies in the same industry.
With a Return On Equity value of -3.23%, AZTA perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 45.52%, AZTA is in line with its industry, outperforming 43.86% of the companies in the same industry.
AZTA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZTA has been increased compared to 1 year ago.
AZTA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AZTA has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.60 indicates that AZTA is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.60, AZTA is doing good in the industry, outperforming 73.68% of the companies in the same industry.
AZTA has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.04, AZTA belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that AZTA is not too dependend on debt financing.
AZTA has a better Debt to Equity ratio (0.00) than 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Altman-Z | 4.6 |
ROIC/WACCN/A
WACC10.94%
2.3 Liquidity
AZTA has a Current Ratio of 2.98. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
AZTA's Current ratio of 2.98 is in line compared to the rest of the industry. AZTA outperforms 54.39% of its industry peers.
AZTA has a Quick Ratio of 2.66. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
AZTA's Quick ratio of 2.66 is in line compared to the rest of the industry. AZTA outperforms 56.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 |
3. Growth
3.1 Past
AZTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.27%, which is quite impressive.
The earnings per share for AZTA have been decreasing by -16.04% on average. This is quite bad
AZTA shows a decrease in Revenue. In the last year, the revenue decreased by -9.52%.
AZTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.86% yearly.
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%
3.2 Future
Based on estimates for the next years, AZTA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.49% on average per year.
AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y50.72%
EPS Next 2Y39.62%
EPS Next 3Y34.08%
EPS Next 5Y27.49%
Revenue Next Year4.54%
Revenue Next 2Y4.91%
Revenue Next 3Y5.21%
Revenue Next 5Y5.37%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 70.75 indicates a quite expensive valuation of AZTA.
AZTA's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of AZTA to the average of the S&P500 Index (27.00), we can say AZTA is valued expensively.
With a Price/Forward Earnings ratio of 46.95, AZTA can be considered very expensive at the moment.
AZTA's Price/Forward Earnings is on the same level as the industry average.
AZTA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.75 | ||
| Fwd PE | 46.95 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AZTA is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, AZTA is valued a bit cheaper than 64.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.87 | ||
| EV/EBITDA | 33.38 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as AZTA's earnings are expected to grow with 34.08% in the coming years.
PEG (NY)1.4
PEG (5Y)N/A
EPS Next 2Y39.62%
EPS Next 3Y34.08%
5. Dividend
5.1 Amount
No dividends for AZTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
37.5
-0.01 (-0.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners111.91%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change11.23%
Market Cap1.72B
Revenue(TTM)593.82M
Net Income(TTM)-55.76M
Analysts75.71
Price Target39.63 (5.68%)
Short Float %9.1%
Short Ratio6.22
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.43%
Min EPS beat(2)8.65%
Max EPS beat(2)36.22%
EPS beat(4)3
Avg EPS beat(4)13.04%
Min EPS beat(4)-29.97%
Max EPS beat(4)37.26%
EPS beat(8)7
Avg EPS beat(8)70.99%
EPS beat(12)10
Avg EPS beat(12)146.49%
EPS beat(16)14
Avg EPS beat(16)123.62%
Revenue beat(2)0
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)4
Avg Revenue beat(12)-1.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.95%
PT rev (1m)16.74%
PT rev (3m)23.64%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)-18.85%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 70.75 | ||
| Fwd PE | 46.95 | ||
| P/S | 2.9 | ||
| P/FCF | 44.87 | ||
| P/OCF | 23.83 | ||
| P/B | 1 | ||
| P/tB | 1.86 | ||
| EV/EBITDA | 33.38 |
EPS(TTM)0.53
EY1.41%
EPS(NY)0.8
Fwd EY2.13%
FCF(TTM)0.84
FCFY2.23%
OCF(TTM)1.57
OCFY4.2%
SpS12.95
BVpS37.66
TBVpS20.12
PEG (NY)1.4
PEG (5Y)N/A
Graham Number21.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.71% | ||
| ROE | -3.23% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 45.52% | ||
| FCFM | 6.45% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.04 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 55.31% | ||
| Cap/Sales | 5.7% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 182.57% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.98 | ||
| Quick Ratio | 2.66 | ||
| Altman-Z | 4.6 |
F-Score5
WACC10.94%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
EPS Next Y50.72%
EPS Next 2Y39.62%
EPS Next 3Y34.08%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-9.52%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%-6.39%
Revenue Next Year4.54%
Revenue Next 2Y4.91%
Revenue Next 3Y5.21%
Revenue Next 5Y5.37%
EBIT growth 1Y70.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year516.37%
EBIT Next 3Y105.29%
EBIT Next 5YN/A
FCF growth 1Y210.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.11%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 4 / 10 to AZTA.
What is the valuation status of AZENTA INC (AZTA) stock?
ChartMill assigns a valuation rating of 3 / 10 to AZENTA INC (AZTA). This can be considered as Overvalued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 2 / 10.
Can you provide the financial health for AZTA stock?
The financial health rating of AZENTA INC (AZTA) is 7 / 10.
How sustainable is the dividend of AZENTA INC (AZTA) stock?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.